Controversies Around Measuring Drug Toxicity: US Food and Drug Administration and Gastrointestinal Perspectives

Gastroenterology. 2020 Jan;158(1):22-27. doi: 10.1053/j.gastro.2019.10.014. Epub 2019 Oct 15.
No abstract available

MeSH terms

  • Biological Products / adverse effects*
  • Congresses as Topic
  • Drug Monitoring / standards*
  • Gastroenterology / standards
  • Gastrointestinal Agents / adverse effects*
  • Gastrointestinal Diseases / drug therapy
  • Humans
  • Metabolism, Inborn Errors / drug therapy
  • Societies, Medical / standards
  • United States
  • United States Food and Drug Administration / standards

Substances

  • Biological Products
  • Gastrointestinal Agents